The Role of P21-Activated Protein Kinase 1 in Metabolic Homeostasis

Total Page:16

File Type:pdf, Size:1020Kb

The Role of P21-Activated Protein Kinase 1 in Metabolic Homeostasis THE ROLE OF P21-ACTIVATED PROTEIN KINASE 1 IN METABOLIC HOMEOSTASIS by YU-TING CHIANG A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Physiology University of Toronto © Copyright by Yu-ting Chiang 2014 The Role of P21-Activated Protein Kinase 1 in Metabolic Homeostasis Yu-ting Chiang Doctor of Philosophy Department of Physiology University of Toronto 2014 Abstract Our laboratory has demonstrated previously that the proglucagon gene (gcg), which encodes the incretin hormone GLP-1, is among the downstream targets of the Wnt signaling pathway; and that Pak1 mediates the stimulatory effect of insulin on Wnt target gene expression in mouse gut non- endocrine cells. Here, I asked whether Pak1 controls gut gcg expression and GLP-1 production, and whether Pak1 deletion leads to impaired metabolic homeostasis in mice. I detected the expression of Pak1 and two other group I Paks in the gut endocrine L cell line GLUTag, and co- localized Pak1 and GLP-1 in the mouse gut. Insulin was shown to stimulate Pak1 Thr423 and β-cat Ser675 phosphorylation. The stimulation of insulin on β-cat Ser675 phosphorylation, gcg promoter activity and gcg mRNA expression could be attenuated by the Pak inhibitor IPA3. Male Pak1-/- mice showed significant reduction in both gut and brain gcg expression levels, and attenuated elevation of plasma GLP-1 levels in response to oral glucose challenge. Notably, the Pak1-/- mice were intolerant to both intraperitoneal and oral glucose administration. Aged Pak1-/- mice showed a severe defect in response to intraperitoneal pyruvate challenge (IPPTT). In primary hepatocytes, however, IPA3 reduced basal glucose production, attenuated glucagon-stimulated glucose production, and inhibited the expression of Pck1 and G6pc. This implicates that the direct effect of group I Paks in hepatocytes is the stimulation of gluconeogenesis, and that the impairment in IPPTT in aged Pak1-/- mice is due to the lack of Pak1 elsewhere. The defect in IPPTT in aged ii Pak1-/- mice could be rescued by stimulating gcg expression with forskolin injection or by enhancing the incretin effect via sitagliptin administration. In summary, my study demonstrates that: 1) Pak1 positively regulates GLP-1 production, 2) Pak1/β-cat signaling plays a role in gut/liver axis or gut/pancreas/liver axis governing glucose homeostasis, and 3) Pak1-/- mice can be utilized as a novel model for metabolic research. iii Acknowledgements I would like to express my deepest gratitude to my supervisor Dr. Tianru Jin, for his continuous support and guidance throughout my studies. He has exemplified the merging of a critical mind with a relentless pursuit of knowledge, which has been and always will be an inspiration to me, both in science and in life. I would like to extend my gratitude toward the members of my Supervisory Committee, my co-supervisor Dr. Michael Wheeler, as well as Dr. Herbert Gaisano and Dr. Qinghua Wang, whose constant encouragement and advice have made the completion of this research project an enjoyable experience. Thanks to all the past and present members of the Jin lab and the TMDT 10th floor diabetes lab, you all made the past few years so much more colorful and memorable. Thanks to Joan and Wilfred for journeying with me, your assistance, advice, and friendship have been invaluable. I want to give special thanks to my parents, David and Lisa, who supported me unconditionally from afar and whose wisdom and love have always been just a Skype call away. Last but not least, I want to thank my sister Helen for the numerous dinner conversations revolving around science, research, Western blots, and mice. Your daily companionship as a sister, friend, and fellow scientist has been a true blessing. This thesis is dedicated to the loving memory of my teacher and mentor Dr. Robert Carsten (Jack) von Borstel (1925-2012) from the University of Alberta, whose immeasurable kindness and encouragements have been instrumental in the completion of all my post-graduate studies. I can do all things through Christ who strengthens me. (Philippians 4:13) iv Table of Contents ABSTRACT ....................................................................................................................................................................................... II TABLE OF CONTENTS .................................................................................................................................................................. V LIST OF FIGURES .......................................................................................................................................................................... IX LIST OF FIGURES ........................................................................................................................................................................... X LIST OF FIGURES .......................................................................................................................................................................... XI LIST OF TABLES .......................................................................................................................................................................... XII LIST OF APPENDICES ............................................................................................................................................................... XIII LIST OF ABBREVIATIONS ....................................................................................................................................................... XIV LIST OF PUBLICATIONS .......................................................................................................................................................... XIX 1 INTRODUCTION ................................................................................................................................................ 1 1.1 DIABETES MELLITUS AND THE METABOLIC SYNDROME ........................................................................................ 2 1.1.1 Diabetes mellitus and the metabolic syndrome ................................................................................................ 2 1.1.2 Major metabolic hormones in glucose homeostasis ....................................................................................... 4 1.1.2.1 Hormones ................................................................................................................................................................................................ 4 1.1.2.2 The pancreas and islets of Langerhans..................................................................................................................................... 5 1.1.2.3 Insulin ....................................................................................................................................................................................................... 6 1.1.2.4 Glucagon ................................................................................................................................................................................................ 11 1.1.2.5 Somatostatin ........................................................................................................................................................................................ 13 1.1.2.6 Pancreatic polypeptide ................................................................................................................................................................... 15 1.1.2.7 Leptin ...................................................................................................................................................................................................... 16 1.1.3 The liver as a central organ in glucose homeostasis ................................................................................... 18 1.1.3.1 Glycogenolysis and glycogenesis ............................................................................................................................................... 19 1.1.3.2 Glycolysis and gluconeogenesis ................................................................................................................................................. 22 1.2 THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE 1 ....................................................................................... 24 1.2.1 Proglucagon gene, GLP-1 production and degradation ............................................................................ 24 1.2.2 Mechanisms underlying proglucagon gene expression ............................................................................. 30 1.2.3 The functions of GLP-1 .............................................................................................................................................. 38 1.3 THE WNT SIGNALING PATHWAY AND PROGLUCAGON GENE EXPRESSION ....................................................... 42 1.3.1 Overview of the Wnt signaling pathway ........................................................................................................... 42 1.3.2 Wnt signaling pathway and metabolic homeostasis .................................................................................. 44 1.3.3 Wnt signaling pathway eFFectors as mediators of proglucagon gene expression ......................... 47 1.4 P21-ACTIVATED PROTEIN KINASE 1 AND ITS ROLE IN METABOLIC HOMEOSTASIS.......................................
Recommended publications
  • The Role of LIM Kinase 1 and Its Substrates in Cell Cycle Progression
    University of Central Florida STARS Electronic Theses and Dissertations, 2004-2019 2014 The Role of LIM Kinase 1 and its Substrates in Cell Cycle Progression Lisa Ritchey University of Central Florida Part of the Medical Sciences Commons Find similar works at: https://stars.library.ucf.edu/etd University of Central Florida Libraries http://library.ucf.edu This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more information, please contact [email protected]. STARS Citation Ritchey, Lisa, "The Role of LIM Kinase 1 and its Substrates in Cell Cycle Progression" (2014). Electronic Theses and Dissertations, 2004-2019. 1300. https://stars.library.ucf.edu/etd/1300 THE ROLE OF LIM KINASE 1 AND ITS SUBSTRATES IN CELL CYCLE PROGRESSION by LISA RITCHEY B.S. Florida State University 2007 M.S. University of Central Florida 2010 A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Burnett School of Biomedical Sciences in the College of Graduate Studies at the University of Central Florida Orlando, Florida Summer Term 2014 Major Professor: Ratna Chakrabarti © 2014 Lisa Ritchey ii ABSTRACT LIM Kinase 1 (LIMK1), a modulator of actin and microtubule dynamics, has been shown to be involved in cell cycle progression. In this study we examine the role of LIMK1 in G1 phase and mitosis. We found ectopic expression of LIMK1 resulted in altered expression of p27Kip1, the G1 phase Cyclin D1/Cdk4 inhibitor.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Potential of the Natural Compound Neocarzilin a As Inhibitor of Cell Migration in Breast Cancer Cells
    Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München The potential of the natural compound Neocarzilin A as inhibitor of cell migration in breast cancer cells Carolin Laura Pyka aus Düsseldorf Deutschland 2019 Erklärung Diese Dissertation wurde im Sinne von §7 der Promotionsordnung vom 28. November 2011 von Frau Prof. Dr. Angelika M. Vollmar betreut. Eidesstattliche Versicherung Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. München, den 18.07.2019 Carolin Laura Pyka Dissertation eingereicht am: 18.07.2019 1. Gutachter: Prof. Dr. Angelika M. Vollmar 2. Gutachter: Prof. Dr. Johanna Pachmayr Mündliche Prüfung am: 28.08.2019 To my family CONTENTS Contents Contents Contents………………………………………………………………………………………………….I List of Figures………………………………………………………………………………………….IV List of Tables…………………………………………………………………………………………...V Abstract………………………………………………………………………………………………VIII 1 Introduction ....................................................................................................................... 1 1.1 Metastatic breast cancer – an overview ........................................................................................ 1 1.1.1 Facts and figures .................................................................................................................... 1 1.1.2 Classification of breast cancer ............................................................................................... 2 1.1.3 Treatment options for metastatic
    [Show full text]
  • Viewer 4.0 Software [73]
    BMC Genomics BioMed Central Research Open Access Bioinformatic search of plant microtubule-and cell cycle related serine-threonine protein kinases Pavel A Karpov1, Elena S Nadezhdina2,3,AllaIYemets1, Vadym G Matusov1, Alexey Yu Nyporko1,NadezhdaYuShashina3 and Yaroslav B Blume*1 Addresses: 1Institute of Food Biotechnology and Genomics, National Academy of Sciences of Ukraine, 04123 Kyiv, Ukraine, 2Institute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russian Federation and 3AN Belozersky Institute of Physical- Chemical Biology, Moscow State University, Leninsky Gory, 119992 Moscow, Russian Federation E-mail: Pavel A Karpov - [email protected]; Elena S Nadezhdina - [email protected]; Alla I Yemets - [email protected]; Vadym G Matusov - [email protected]; Alexey Yu Nyporko - [email protected]; Nadezhda Yu Shashina - [email protected]; Yaroslav B Blume* - [email protected] *Corresponding author from International Workshop on Computational Systems Biology Approaches to Analysis of Genome Complexity and Regulatory Gene Networks Singapore 20-25 November 2008 Published: 10 February 2010 BMC Genomics 2010, 11(Suppl 1):S14 doi: 10.1186/1471-2164-11-S1-S14 This article is available from: http://www.biomedcentral.com/1471-2164/11/S1/S14 Publication of this supplement was made possible with help from the Bioinformatics Agency for Science, Technology and Research of Singapore and the Institute for Mathematical Sciences at the National University of Singapore. © 2010 Karpov et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Effects of the Pseudorabies Virus US3 Protein Kinase on Actin and Actin-Controlling Proteins
    Universiteit Gent Faculteit Diergeneeskunde Vakgroep Virologie, Parasitologie en Immunologie Effects of the pseudorabies virus US3 protein kinase on actin and actin-controlling proteins Thary Jacob Proefschrift voorgedragen tot het behalen van de graad van Doctor in de Diergeneeskundige Wetenschappen, 2015 Promotor: Prof. dr. H. Favoreel ISBN: 9789058644459 © 2015 The author and the promoters give the authorization to consult and copy parts of this work for personal use only. Every other use is subject to copyright laws. The author should obtain written permission to reproduce any material contained in this work. Thary Jacob is supported by a personal PhD grant from the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen). This research was supported by a grant from the F.W.O.- Vlaanderen (Grant G.0835.09) and the Research Council of Ghent University (Concerted Research Action 01G01311). About the cover The front cover shows LifeAct (red) transduced swine testicle cells that were transfected with a plasmid encoding PRV US3. US3 protein was stained with primary mouse anti-US3 antibody and secondary FITC-labeled (green) anti-mouse antibody. Nuclei were counterstained with Hoechst 33342 (cyan). This image was taken using a Leica TCS SPE confocal microscope (XY length: 174.6 x 174.6 µm; Z = 6,8 µm, objective: ACS APO 63.0 x 1.30 (oil)). “What is written without effort is, in general, read without pleasure.” - Samuel Johnson Table of contents Abbreviation list .........................................................................................................................
    [Show full text]
  • The Role of the Rho Gtpases in Neuronal Development
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The role of the Rho GTPases in neuronal development Eve-Ellen Govek,1,2, Sarah E. Newey,1 and Linda Van Aelst1,2,3 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 11724, USA; 2Molecular and Cellular Biology Program, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA Our brain serves as a center for cognitive function and and an inactive GDP-bound state. Their activity is de- neurons within the brain relay and store information termined by the ratio of GTP to GDP in the cell and can about our surroundings and experiences. Modulation of be influenced by a number of different regulatory mol- this complex neuronal circuitry allows us to process that ecules. Guanine nucleotide exchange factors (GEFs) ac- information and respond appropriately. Proper develop- tivate GTPases by enhancing the exchange of bound ment of neurons is therefore vital to the mental health of GDP for GTP (Schmidt and Hall 2002); GTPase activat- an individual, and perturbations in their signaling or ing proteins (GAPs) act as negative regulators of GTPases morphology are likely to result in cognitive impairment. by enhancing the intrinsic rate of GTP hydrolysis of a The development of a neuron requires a series of steps GTPase (Bernards 2003; Bernards and Settleman 2004); that begins with migration from its birth place and ini- and guanine nucleotide dissociation inhibitors (GDIs) tiation of process outgrowth, and ultimately leads to dif- prevent exchange of GDP for GTP and also inhibit the ferentiation and the formation of connections that allow intrinsic GTPase activity of GTP-bound GTPases (Zalc- it to communicate with appropriate targets.
    [Show full text]
  • Phosphorylation Sites in Protein Kinases and Phosphatases Regulated by Formyl Peptide Receptor 2 Signaling
    International Journal of Molecular Sciences Review Phosphorylation Sites in Protein Kinases and Phosphatases Regulated by Formyl Peptide Receptor 2 Signaling Maria Carmela Annunziata 1, Melania Parisi 1, Gabriella Esposito 2 , Gabriella Fabbrocini 1, Rosario Ammendola 2 and Fabio Cattaneo 2,* 1 Department of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; [email protected] (M.C.A.); [email protected] (M.P.); [email protected] (G.F.) 2 Department of Molecular Medicine and Medical Biotechnology, School of Medicine,, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; [email protected] (G.E.); [email protected] (R.A.) * Correspondence: [email protected]; Fax: +39-081-7464-359 Received: 5 May 2020; Accepted: 25 May 2020; Published: 27 May 2020 Abstract: FPR1, FPR2, and FPR3 are members of Formyl Peptides Receptors (FPRs) family belonging to the GPCR superfamily. FPR2 is a low affinity receptor for formyl peptides and it is considered the most promiscuous member of this family. Intracellular signaling cascades triggered by FPRs include the activation of different protein kinases and phosphatase, as well as tyrosine kinase receptors transactivation. Protein kinases and phosphatases act coordinately and any impairment of their activation or regulation represents one of the most common causes of several human diseases. Several phospho-sites has been identified in protein kinases and phosphatases, whose role may be to expand the repertoire of molecular mechanisms of regulation or may be necessary for fine-tuning of switch properties. We previously performed a phospho-proteomic analysis in FPR2-stimulated cells that revealed, among other things, not yet identified phospho-sites on six protein kinases and one protein phosphatase.
    [Show full text]
  • Characterisation of a Protein Kinase B Inhibitor in Vitro and in Insulin Treated Liver Cells
    Diabetes In Press, published online June 11, 2007 Characterisation of a protein kinase B inhibitor in vitro and in insulin treated liver cells. Received for publication 17 March 2007 and accepted in revised form 5 June 2007. Additional information for this article can be viewed in an online appendix at http://diabetes.diabetesjournals.org Lisa Logie, Antonio J. Ruiz-Alcaraz, Michael Keane*$, Yvonne L. Woods*, Jennifer Bain*, Rudolfo Marquez$, Dario R. Alessi* and Calum Sutherland. Division of Pathology and Neuroscience, *MRC Protein Phosphorylation Unit, $Division of Biological Chemistry, University of Dundee, Dundee, Scotland. Corresponding author Dr Calum Sutherland Pathology and Neurosciences University of Dundee, Ninewells Hospital Dundee, Scotland, UK, DD1 9SY email: [email protected] Word Count: 3978, Tables: 2, Figures: 6. Keywords: PKB, AKT, PEPCK, insulin, Akti-1/2, diabetes. Abbreviations: PKB, protein kinase B; G6Pase, glucose-6-phosphatase; PEPCK, phosphoenolpyruvate carboxykinase; IGFBP1, IGF binding protein-1; TIRE, thymine-rich insulin response element; PRAS40, proline rich akt substrate of 40kDa; Akti, Akt inhibitor. Running Title: PKB inhibition and insulin action. Copyright American Diabetes Association, Inc., 2007 Abstract: Objective: Abnormal expression of the hepatic gluconeogenic genes (glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK)) contributes to hyperglycemia. These genes are repressed by insulin but this process is defective in diabetes. Protein kinase B (PKB) is implicated in this action of insulin. An inhibitor of PKB, termed Akti-1/2, was recently reported, however the specificity and efficacy against insulin induced PKB was not reported. Our aim was to characterise the specificity and efficacy of Akti-1/2 in cells exposed to insulin and then establish whether inhibition of PKB is sufficient to prevent regulation of hepatic gene expression by insulin.
    [Show full text]
  • Proximity Proteomics Identifies PAK4 As a Component of Afadin–Nectin
    ARTICLE https://doi.org/10.1038/s41467-021-25011-w OPEN Proximity proteomics identifies PAK4 as a component of Afadin–Nectin junctions Yohendran Baskaran 1,5, Felicia Pei-Ling Tay2,5, Elsa Yuen Wai Ng1, Claire Lee Foon Swa 3, Sheena Wee 3, ✉ Jayantha Gunaratne3 & Edward Manser 1,4 Human PAK4 is an ubiquitously expressed p21-activated kinase which acts downstream of Cdc42. Since PAK4 is enriched in cell-cell junctions, we probed the local protein environment 1234567890():,; around the kinase with a view to understanding its location and substrates. We report that U2OS cells expressing PAK4-BirA-GFP identify a subset of 27 PAK4-proximal proteins that are primarily cell-cell junction components. Afadin/AF6 showed the highest relative biotin labelling and links to the nectin family of homophilic junctional proteins. Reciprocally >50% of the PAK4-proximal proteins were identified by Afadin BioID. Co-precipitation experiments failed to identify junctional proteins, emphasizing the advantage of the BioID method. Mechanistically PAK4 depended on Afadin for its junctional localization, which is similar to the situation in Drosophila. A highly ranked PAK4-proximal protein LZTS2 was immuno- localized with Afadin at cell-cell junctions. Though PAK4 and Cdc42 are junctional, BioID analysis did not yield conventional cadherins, indicating their spatial segregation. To identify cellular PAK4 substrates we then assessed rapid changes (12’) in phospho-proteome after treatment with two PAK inhibitors. Among the PAK4-proximal junctional proteins seventeen PAK4 sites were identified. We anticipate mammalian group II PAKs are selective for the Afadin/nectin sub-compartment, with a demonstrably distinct localization from tight and cadherin junctions.
    [Show full text]
  • Covalent Aurora a Regulation by the Metabolic Integrator Coenzyme A
    bioRxiv preprint doi: https://doi.org/10.1101/469585; this version posted November 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Covalent Aurora A regulation by the metabolic integrator coenzyme A Yugo Tsuchiya1#, Dominic P Byrne2#, Selena G Burgess3#, Jenny Bormann4, Jovana Bakovic1, Yueyan Huang1, Alexander Zhyvoloup1, Sew Peak-Chew5, Trang Tran6, Fiona Bellany6, Alethea Tabor6, AW Edith Chan7, Lalitha Guruprasad8, Oleg Garifulin9, Valeriy Filonenko9, Samantha Ferries10, Claire E Eyers10, John Carroll4^, Mark Skehel5, Richard Bayliss3*, Patrick A Eyers2* and Ivan Gout1,9* 1Department of Structural and Molecular Biology, University College London, London WC1E 6BT, UK 2Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK 3School of Molecular and Cellular Biology, Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK 4Department of Cell and Developmental Biology, University College London, London WC1E 6BT, UK 5MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK 6Department of Chemistry, University College London, London WC1E 6BT, UK 7Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, UK 8School of Chemistry, University of Hyderabad, Hyderabad 500 046, India 9Department of Cell
    [Show full text]